|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn646756569 |
003 |
OCoLC |
005 |
20231117033226.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
960814s2002 ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d UBY
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCA
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d SFB
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 505149401
|a 1127172042
|a 1136352404
|a 1144233829
|a 1162265815
|
020 |
|
|
|a 0444510540
|q (electronic bk.)
|
020 |
|
|
|a 9780444510549
|q (electronic bk.)
|
020 |
|
|
|a 1281715891
|
020 |
|
|
|a 9781281715890
|
020 |
|
|
|a 9786611715892
|
020 |
|
|
|a 6611715894
|
020 |
|
|
|a 0080515207
|
020 |
|
|
|a 9780080515205
|
035 |
|
|
|a (OCoLC)646756569
|z (OCoLC)505149401
|z (OCoLC)1127172042
|z (OCoLC)1136352404
|z (OCoLC)1144233829
|z (OCoLC)1162265815
|
050 |
|
4 |
|a RS410
|b .P7640 2002eb
|
082 |
0 |
4 |
|a 615.1/9
|2 23
|
245 |
0 |
0 |
|a Progress in medicinal chemistry.
|n Volume 40 /
|c editors, F.D. King and A.W. Oxford.
|
260 |
|
|
|a Amsterdam :
|b North Holland Pub. Co.,
|c �2002.
|
300 |
|
|
|a 1 online resource (x, 150 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Progress in medicinal chemistry ;
|v 40
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Progress in Medicinal Chemistry, Volume 40; Copyright Page; Contents; Preface; List of Contributors; Chapter 1. The Discovery and Development of Atorvastatin, a Potent Novel Hypolipidemic Agent; Chapter 2. Discovery of CEP-1347/KT-7515, an Inhibitor of the JNK/SAPK Pathway for the Treatment; Chapter 3. Discovery of Second Generation Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors of HIV-1; Chapter 4. Molecular Modeling of Opioid Receptor-Ligand Complexes; Subject Index; Author Index (Vols. 1-40); Subject Index (Vols. 1-40)
|
520 |
|
|
|a PROGRESS MEDICINAL CHEM PMC40H.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
650 |
|
7 |
|a Pharmacology.
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a King, Frank D.
|
700 |
1 |
|
|a Oxford, Arnold Whitaker,
|d 1854-
|
776 |
|
|
|z 0-444-51054-0
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444510549
|z Texto completo
|